Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Mintz, M
   Clinical features and treatment interventions for human immunodeficiency virus-associated neurologic disease in children
   SEMINARS IN NEUROLOGY
   
   M. Mintz, "Clinical features and treatment interventions for human immunodeficiency virus-associated neurologic disease in children", SEM NEUROL, 19(2), 1999, pp. 165-176
2. MINTZ M
   NEUROLOGICAL AND DEVELOPMENTAL PROBLEMS IN PEDIATRIC HIV-INFECTION
   The Journal of nutrition
   
   M. Mintz, "NEUROLOGICAL AND DEVELOPMENTAL PROBLEMS IN PEDIATRIC HIV-INFECTION", The Journal of nutrition, 126(10), 1996, pp. 2663-2673
3. MINTZ M
   CARNITINE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME
   Journal of child neurology
   
   M. Mintz, "CARNITINE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME", Journal of child neurology, 10, 1995, pp. 2
4. HIRSCH MS; DAQUILA RT
   THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
   The New England journal of medicine
   
   M.S. Hirsch e R.T. Daquila, "THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION", The New England journal of medicine, 328(23), 1993, pp. 1686-1695
5. WILLIAMS TM; CICCARONE TM; MACTOUGH SC; ROONEY CS; BALANI SK; CONDRA JH; EMINI EA; GOLDMAN ME; GREENLEE WJ; KAUFFMAN LR; OBRIEN JA; SARDANA VV; SCHLEIF WA; THEOHARIDES AD; ANDERSON PS
   5-CHLORO-3-(PHENYLSULFONYL)INDOLE-2-CARBOXAMIDE - A NOVEL, NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE
   Journal of medicinal chemistry
   
   T.M. Williams et al., "5-CHLORO-3-(PHENYLSULFONYL)INDOLE-2-CARBOXAMIDE - A NOVEL, NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE", Journal of medicinal chemistry, 36(9), 1993, pp. 1291-1294